EUCTR2012-005197-63-ES进行中（未招募）1 期
Effect of liraglutide on physical performance: a randomised, double-blind, controlled study in patiens with type 2 diabetes. - LIPER2
Ana M. Wägner0 个研究点开始时间: 2012年12月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Type 2 diabetes treated with oral agents (including metformin if tolerated and not contraindicated), a maximum of 2 intermediate-long acting insulin injections per day or a combination of both.
- •-HbA1c between 7 and 10 %.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 22
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 8
排除标准
- •Severe renal failure (estimated CFR<30ml/min)
- •Liver failure (child-pugh score > 6 points)
- •Present or planned pregnancy/breastfeeding or inadequate contraception
- •intolerance/allergy to liraglutide
- •Familiar/personal history of medullary thyroid cancer or multiple endocrine neoplasia 2
- •personal history of pancreatitis
- •triglyceride concentrations above 500mg/dl or alcohol intake>40 grams/day
- •known active malignancy
- •tratment with GLP1 agonist or DPP4 inhibitors in the previous 3 months
- •factors potentially interfering with adherence to treatment or follow-up (investigator´s criteria)
- •known coronary artery disease with exercise-induced ischaemia
- •planned revascularisations in the following 6 months
- •severe symptoms of heart failure (NYHA class IV)
研究者
相似试验
招募中
2 期
The effect of Liraglutide on clinical and paraclinical symptoms in patients with polycystic ovary syndromeIRCT20220720055510N1Shahre-kord University of Medical Sciences35
进行中（未招募）
1 期
Comparing the effects of two new therapies for diabetes on the heart, measures of fat and diabetes in young people with type 2 diabetesType 2 Diabetes MellitusEUCTR2012-002422-78-GBniversity of Leicester90
进行中（未招募）
1 期
Efficacy and tolerance of Liraglutide for weight loss in obese type 2 diabetic hemodialysis patientsEUCTR2020-000043-31-FRGroupe Hospitalier Paris Saint-Joseph30
进行中（未招募）
1 期
A comparative study of the effects of Liraglutide and Acarbose on glycaemic control, weight and Health-Related Quality-of-life(HRQOL) in Overweight type 2 Diabetic patients on Oral Hypoglycemic Agents (OHA's)+ high doses of insulin. - Liraglutide & Acarbose effect on HbA1c, Wt and HRQOL in type2 DiabetesType-2 Diabetes MellitusEUCTR2010-020193-42-GBHywel DdA Health Borad66
进行中（未招募）
1 期
The effect of liraglutide compared to sitagliptin, both in combination with metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, active comparator, three-armed, parallel-group, multi-centre, multi-national trialtype 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-003937-17-NLovo Nordisk A/S